| Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC VS Raj, H Mou, SL Smits, DHW Dekkers, MA Müller, R Dijkman, D Muth, ... Nature 495 (7440), 251-254, 2013 | 2352 | 2013 |
| SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ... Nature communications 11 (1), 6013, 2020 | 996 | 2020 |
| The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity L Zhang, CB Jackson, H Mou, A Ojha, ES Rangarajan, T Izard, M Farzan, ... BioRxiv, 2020 | 576 | 2020 |
| The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing … H Mou, VS Raj, FJM Van Kuppeveld, PJM Rottier, BL Haagmans, ... Journal of virology 87 (16), 9379-9383, 2013 | 246 | 2013 |
| Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 T Ou, H Mou, L Zhang, A Ojha, H Choe, M Farzan PLoS pathogens 17 (1), e1009212, 2021 | 211 | 2021 |
| The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement BD Quinlan, H Mou, L Zhang, Y Guo, W He, A Ojha, MS Parcells, G Luo, ... Biorxiv, 2020.04. 10.036418, 2020 | 147 | 2020 |
| Specific serology for emerging human coronaviruses by protein microarray C Reusken, H Mou, GJ Godeke, L van der Hoek, B Meyer, MA Müller, ... Eurosurveillance 18 (14), 2013 | 125 | 2013 |
| Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody K Ohnuma, BL Haagmans, R Hatano, VS Raj, H Mou, S Iwata, NH Dang, ... Journal of virology 87 (24), 13892-13899, 2013 | 111 | 2013 |
| A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo G Zhong, H Wang, W He, Y Li, H Mou, ZJ Tickner, MH Tran, T Ou, Y Yin, ... Nature biotechnology 38 (2), 169-175, 2020 | 69 | 2020 |
| The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv 2020 L Zhang, CB Jackson, H Mou, A Ojha, ES Rangarajan, T Izard, M Farzan, ... Google Scholar, 0 | 52 | |
| Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 H Mou, BD Quinlan, H Peng, G Liu, Y Guo, S Peng, L Zhang, ... PLoS pathogens 17 (4), e1009501, 2021 | 34 | 2021 |
| The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies H Mou, VS Raj, FJM van Kuppeveld, PJM Rottier, BL Haagmans, ... Coronavirus spike-receptor interactions 87 (16), 65, 2015 | 31 | 2015 |
| Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence FM Mou H, Zhong G, Gardner MR, Wang H, Wang YW, Cheng D Molecular Therapy, 2018 | 26 | 2018 |
| Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2 H Mou, BD Quinlan, H Peng, Y Guo, S Peng, L Zhang, ME Davis-Gardner, ... BioRxiv, 2020 | 25 | 2020 |
| A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020 MH Tran, H Park, CL Nobles, P Karunadharma, L Pan, G Zhong, H Wang, ... Molecular Therapy-Nucleic Acids 24, 40-53, 2021 | 23 | 2021 |
| Identification of potent small molecule inhibitors of SARS-CoV-2 entry S Mediouni, H Mou, Y Otsuka, JA Jablonski, RS Adcock, L Batra, ... Slas Discovery 27 (1), 8-19, 2022 | 20 | 2022 |
| Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells C Riou, G Schäfer, E Du Bruyn, RT Goliath, C Stek, H Mou, D Hung, ... European Respiratory Journal 59 (1), 2022 | 19 | 2022 |
| An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines Y Guo, W He, H Mou, L Zhang, J Chang, S Peng, A Ojha, R Tavora, ... Mbio 12 (3), 10.1128/mbio. 00930-21, 2021 | 18 | 2021 |
| Identification of protein receptors for coronaviruses by mass spectrometry VS Raj, MM Lamers, SL Smits, JAA Demmers, H Mou, BJ Bosch, ... Coronaviruses: methods and protocols, 165-182, 2015 | 11 | 2015 |
| Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens ET Crooks, F Almanza, A D’addabbo, E Duggan, J Zhang, K Wagh, ... PLoS pathogens 17 (10), e1009807, 2021 | 9 | 2021 |
Michael FarzanProfessor of Pediatrics, Harvard Medical SchoolVerified email at childrens.harvard.edu
